Benicar Lawsuits are now being filed on behalf of people who were seriously injured by the side effects of this controversial blood pressure medication. Over the past several years, Benicar has been linked to chronic diarrhea, intestinal complications, sprue-like enteropathy, Celiac disease, and many other serious problems. Symptoms of Benicar side effects may take months or even years to develop after the patient begins a regimen with the drug.
Free Benicar Lawsuit Evaluation: If you or a loved one has been injured by the side effects of Benicar (olmesartan), you should contact our law firm immediately. You may be entitled to compensation by filing a Benicar lawsuit and we can help.
What is Benicar?
Benicar (generic: olmesartan medoxomil) is an angiotensin II receptor antagonist blood pressure medication. The drug is designed to keep blood vessels from narrowing, which lowers blood pressure and increases blood flow. Benicar is prescribed for the treatment of high blood pressure (hypertension) in adults and children who are at least six years old. Benicar is made by Daiichi Sankyo, and was approved by the U.S. Food & Drug Administration (FDA) in 2002.
Benicar Side Effects
Serious side effects of Benicar may include:
- Chronic diarrhea
- Intestinal problems
- Sprue-like enteropathy
- Celiac disease
- Acute kidney disease
- Bloody urine
- Muscle damage
- Irregular heartbeat
- High levels of uric acid in the blood
- Life-threatening allergic reactions
- Giant hives
- Low blood pressure
Other, less severe side effects of Benicar may include:
- Inflammation of the Lining of the Stomach and Intestines
- Hair Loss
- Joint Pain
- Muscle Pain
- Sensation of Spinning or Whirling
- Fluid Retention in the Legs, Feet, Arms or Hands
- Puffy Face from Water Retention
- Chest Pain
- Throwing Up
- Stomach Cramps
- Feeling Weak
- High Cholesterol
- High Amount of Potassium in the Blood
FDA Approves Benicar Label Changes to Include Intestinal Problems (Sprue-Like Enteropathy)
On July 7, 2013, the FDA issued a warning stating that Benicar, Benicar HCT, Azor, Tribenzor, and generics had been linked to a severe intestinal problem called sprue-like enteropathy. As a result, the agency required changes to the labels of these drugs to include information regarding this concern. According to the FDA:
Symptoms of sprue-like enteropathy include severe, chronic diarrhea with substantial weight loss. The enteropathy may develop months to years after starting olmesartan, and sometimes requires hospitalization (see Data Summary). If patients taking olmesartan develop these symptoms and no other cause is found, the drug should be discontinued, and therapy with another antihypertensive started. Discontinuation of olmesartan has resulted in clinical improvement of sprue-like enteropathy symptoms in all patients.
Benicar Lawsuit Filed Over Chronic Diarrhea, Intestinal Complications
In February 2014, a Benicar lawsuit was filed on behalf of a Texas man who claims he suffered severe intestinal problems from side effects of the drug, which caused him to have chronic diarrhea that required hospitalization for over 100 days. The suit was filed by George Edward William and his wife Martha in New Jersey Superior Court, but the drugmakers have since transferred the case to the U.S. District Court for the District of New Jersey.
According to allegations raised in the complaint, Williams suffered chronic diarrhea, dehydration, weight loss, nausea, vomiting and malnutrition for a number of years while taking Benicar. Because physicians were unaware that Benicar had the potential to cause intestinal complications, Williams was hospitalized more than 10 times over the previous 4 years, spending more than 100 days in the hospital as doctors tried to determine the cause of his symptoms. As a result, Williams allegedly suffered a back fracture and cataracts on his eyes caused by steroids he was given, and has been left with permanent damage to his intestines that requires him to use a feeding tube.
The Benicar lawsuit accuses Daiichi Sankyo of overly-aggressive marketing of the product, noting that the company spent $1 billion on promotional spending between 2002 and 2008, calling it an “ARB with superior efficacy.” However, in 2006 the Food & Drug Administration found that these claims were unsubstantiated and accused the company of putting out false and misleading statements, noting that the marketing information failed to include Benicar health risk information.
Do I have a Benicar Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Benicar lawsuits. We are handling individual litigation nationwide and currently accepting new Benicar injury and death cases in all 50 states.
Free Benicar Lawsuit Evaluation: Again, If you or a loved one has been injured by the side effects of Benicar (olmesartan medoxomil), you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.